跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEXMEDETOMIDINE-AFT dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
DEXMEDETOMIDINE-AFT dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection ampoule
Approved
STANDARD
DEXMEDETOMIDINE-AFT dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection ampoule
AFT Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
0b913feb3d815554
Company
AFT Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
0b913feb3d815554
Product Name
DEXMEDETOMIDINE-AFT dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection ampoule
Artg Id
396293
Artg Name
DEXMEDETOMIDINE-AFT dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection ampoule
Sponsor
AFT Pharmaceuticals Pty Ltd
Company Detail Path
/organization/aft-pharmaceuticals-au-pty-ltd
Artg Date
2023-08-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/b900c615abd290e7ae9245d03518c5b6.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/3cd727f07efbcf9384a6dbfd78d1dd48.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
0b913feb3d815554
Type
Standard
Back to TGA Approvals